Throughout history, brilliant minds have tried to figure out the secret behind living longer. Much of the research has credited diet and exercise, but a group of scientists expanded on previous data ...
Blueprint Medicines Corporation BPMC announced encouraging initial data from the dose-finding part 1 of phase II PIONEER study on its lead candidate avapritinib for treating patients with indolent ...
Real-world analysis shows BluePrint® identifies chemotherapy-sensitive Basal-type tumors among MammaPrint® High Risk HR+ HER2- breast cancers, supporting more personalized treatment strategies IRVINE, ...
Blueprint Medicines Corporation BPMC announced that the FDA placed a partial clinical hold on the phase I/II study of pipeline candidate BLU-222. The company is developing investigational inhibitor, ...
Blueprint Medicines Corporation BPMC announced encouraging initial data from the dose-finding part 1 of phase II PIONEER study on its lead candidate avapritinib for treating patients with indolent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback